Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T16:36:51.307Z.
Calculation as of: 2026-10-06T16:36:51.307Z.
Quote observation: 2026-10-06T16:29:24.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4a3a0e03002c1ec33ed026058caacdcc2374dd3411b27b5cd001974e391cfa1f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
Market Cap
$38.04M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$38.88M
Price/OCF Ratio
59.90
TTM Avg
12.39
3Y Avg
12.73
5Y Avg
32.12
Market Cap
$35.10M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | $37.33M | N/A | N/A | N/A | N/A |
| QT Imaging Holdings, Inc. (QTI)vs › | $36.76M | N/A | N/A | N/A | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $38.04M | N/A | N/A | N/A | N/A |
| Elicio Therapeutics, Inc. (ELTX)vs › | $36.42M | N/A | N/A | N/A | N/A |
| DocGo Inc. (DCGO)vs › | $35.92M | N/A | 2.00 | 3.35 | 33.77 |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.88M | 59.90 | 12.39 | 12.73 | 32.12 |
| Elutia Inc (ELUT)vs › | $35.15M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.10M | N/A | N/A | N/A | N/A |
| Nephros, Inc. (NEPH)vs › | $39.84M | N/A | 33.35 | 46.22 | 46.22 |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.50M | N/A | N/A | N/A | N/A |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
